Introduction
Atopic dermatitis (AD) is a chronic relapsing eczematous skin disease characterized by pruritus and inflammation with cutaneous physiological dysfunction. Long-lasting itching is an intolerable sensation for patients with severe AD. Psychosocial stresses such as human relationships, pressures of work, worries about career, and anxieties for independence affect the skin condition of patients with AD. Such patients tend to have habitual scratching behavior called"addictive scratching" or"scratch dependence" ; this behavior worsens their eruptions gradually and forms a vicious cycle called the ʻitch-scratch cycleʼ. Therefore, treatments are necessary for both the physical and the mental conditions of the patients 1) 2)
. We term these adverse conditions of AD as"behavioral and psychological symptoms of atopic dermatitis (BPSA)"(Figure-1) and it has become an issue of public concern. Effective anti-pruritic and anti-BPSA drugs are needed by intractable AD patients. We introduce the knowledge of yokukansan in dermatological field, at the center of our research results to explore the possibility of treatment of severe AD.
NC/Nga mice have been regarded as an excellent model for AD since they develop AD-like skin lesions spontaneously under conventional conditions, but not under specific pathogen free (SPF) conditions 3) . Before starting our study, we assessed the effects of the environment and stress on the skin of NC/Nga mice by comparing the mice bred in groups with those that were kept isolated under conventional conditions and under SPF conditions, respectively. It is well known that individually housed mice undergo strong social stress because mice are social animals that live in groups in the natural environment, measurements were made of dermatitis scores, transepidermal water loss (TEWL), scratching behaviors as well as grooming behaviors. Under SPF conditions, dermatitis was not observed either in the group housed or the individually housed animals. In that study, we used
Figure-1 Patient with severe AD tend to suffer from depression and/or sleeplessness, and to have habitual scratching behavior called"addictive scratching" or "scratch dependence" ; this behavior worsens their eruptions gradually and forms a vicious cycle called theʻitch-scratch cycleʼ . Therefore, treatments are necessary for both the physical and the mental conditions of the patients. We term these adverse conditions of AD as"behavioral and psychological symptoms of atopic dermatitis (BPSA)" .
Figure-2
We assessed the effects of the environment and stress on the skin of NC/Nga mice by comparing the mice bred in groups with those that were kept isolated under conventional conditions and under SPF conditions, respectively. It is well known that individually housed mice undergo strong social stress because mice are social animals that live in groups in the natural environment. In this study, we used data derived from the isolated mice kept under SPF conditions as a SPF control, which had no skin lesions. The results showed that isolated NC/Nga mice kept under conventional conditions manifested the most severe dermatitis with increased scratching behaviors and pathological grooming behaviors.
data derived from the isolated mice kept under SPF conditions as a SPF control, which had no skin lesions. The results showed that isolated NC/Nga mice kept under conventional conditions manifested the most severe dermatitis with increased scratching behaviors and pathological grooming behaviors (data not shown). We concluded that socially isolated NC/Nga mice kept under conventional conditions exhibit skin lesions similar to those of human AD patients with BPSA under stressful conditions ( Figure-2 . Thus, YKS is a notable Kampo medicine in various fields.
In our previous study using NC/Nga mice, YKS-controlled scratching behaviors inhibited the development of AD-like lesions and showed a "preventive effect"as well as a"therapeutic effect" on dermatitis 16) . However, the mechanism by which YKS controls scratching behaviors and inhibits the development of AD-like lesions in NC/Nga mice remains unexplored. In second study 37) , we investigated the effects of YKS on the development of AD-like lesions in socially isolated NC/Nga mice and compared its effects with those of fexofenadine, a histamine H1-receptor antagonist.
Time courses of dermatitis scores, TEWL and the numbers of scratching behaviors and grooming behaviors
Dermatitis scores of the conventional control group were aggravated as time goes on. Both the YKS-and the fexofenadine-treated groups significantly inhibited the aggravation of skin lesions in NC/Nga mice from 3 weeks after the start of the experiments. The dermatitis score of the SPF control group was not more than a minor increase ( Figure-4A ). The TEWL of the conventional control group was increased as time goes on. The YKS-and the fexofenadine-treated groups significantly inhibited the increase of TEWL compared with the conventional control mice from 3 weeks. The TEWL of the SPF group, which had no skin lesions, was not increased (Figure-4B ). Scratching behaviors of the conventional control and the fexofenadine-treated groups increased as time goes on. The YKS-treated group significantly decreased the scratching behaviors compared with the conventional control group after 6 weeks. The scratching behaviors of the SPF group was not increased (Figure-4C ). Grooming behaviors of the A. The skin lesions of the conventional control group were aggravated as time goes on. Both the YKS-and the fexofenadine-treated groups significantly inhibited the aggravation of skin lesions in NC/Nga mice from 3 weeks after the start of the experiments. The dermatitis score of the SPF control group was not more than a minor increase. B. Scratching behaviors of the conventional control and the fexofenadine-treated groups increased as time goes on. The YKS-treated group significantly decreased the scratching behaviors compared with the conventional control group after 6 weeks. The scratching behaviors of the SPF group were not increased. C. Grooming behaviors of the conventional control group and also the fexofenadine-treated group were increased under social isolated conditions. The YKS-treated group significantly decreased the grooming behaviors compared with the conventional control mice from 3 weeks. The grooming behaviors of the SPF group increased under social isolated conditions. D. The TEWL of the conventional control group was increased as time goes on. The YKS-and the fexofenadine-treated groups significantly inhibited the increase of TEWL compared with the conventional control mice from 3 weeks. The TEWL of the SPF group, which had no skin lesions, was not increased. SPF control: unfilled circle, conventional control: filled circle, YKS: filled square, fexofenadine: filled circle.
conventional control group and the fexofenadine-treated group were increased under social isolated conditions. The YKS-treated group significantly decreased the grooming behaviors compared to the conventional control mice from 3 weeks. The grooming behaviors of the SPF group increased under social isolated conditions (Figure-4D) .
Assessment of the number of infiltrating mast cells in the skin of NC/Nga mice
Using histological examination, the numbers of mast cells infiltrating the skin were enumerated. The numbers of infiltrating mast cells in 0.25 × 0.25 mm (0.0625 mm 2 ) squares were counted using a microscope. The numbers of infiltrating mast cells in the YKS-treated or the fexofenadinetreated mice were significantly decreased compared with the conventional control mice (Figure-5A ).
RT-PCR analyses of NMDA receptor, glutamate aspartate transporter, excitatory amino-acid carrier 1 and glutamate transporter-1 in the skin of NC/Nga mice
The level of NMDA receptor mRNA in the skin was significantly increased in the conventional control mice compared with the SPF control mice, and was significantly decreased in the YKS-treated mice compared with the conventional control mice (Figure-5B ). The level of glutamate transporter-1 (GLT-1) mRNA in the skin was decreased in the conventional control mice compared with the SPF control mice and the YKS-treated mice. The levels of glutamate aspartate transporter (GLAST) and excitatory amino-acid carrier 1 (EAAC1) mRNAs were not significantly different among the four groups (data not shown).
Article consideration
The results of our study demonstrate that the traditional Japanese medicine, YKS, ameliorates the development of AD-like lesions and the increase in TEWL and also decreases the number of scratching behaviors and pathological grooming behaviors in socially isolated NC/Nga mice. It is also shown that NMDA receptors and GLT-1 in the skin are involved in the AD-like skin lesions of NC/Nga mice. YKS ameliorated the AD-like skin lesions as well as fexofenadine as shown in the present study.
In our previous study, we demonstrated that YKS ameliorates the AD-like skin lesions in a dosedependent manner in NC/Nga mice 16) . In the present study, we utilized a Microact ® to count the scratching behaviors of the animals, which provides a more objective and accurate evaluation of scratching behaviors as compared with visual counting by the investigators. Long-lasting ([1.5 s] scratching behaviors were counted, so that scratching behaviors which are equivalent to human"addictive scratching"were evaluated in NC/Nga mice 17)
. YKS significantly inhibited scratching behaviors compared with the conventional control mice and the fexofenadine-treated mice in which the numbers of scratching behaviors gradually increased. Although grooming behaviors are intrinsically essential in many animal species, anxiety and/or stress induce (s) the increase in involuntary grooming behaviors, which leads to inflammation, erosion, and/or ulceration in the skin. Such behaviors are also known to increase in mice that are models for obsessive compulsive disorder 18)-20)
. Obsessivecompulsive disorder is an anxiety disorder and is characterized by persistent intrusive thoughts (obsessions) and repetitive behaviors (compulsions). Our experimental results show that YKS reduces the numbers of aberrant grooming behaviors compared with the conventional control mice and the fexofenadine-treated mice, i. e., it was shown that YKS alleviates excessive anxiety and/or stress in NC/Nga mice. Our experimental results suggest that YKS acts on the central nervous system (CNS) inducing a tranquilizing effect.
Itching is one of the major diagnostic criteria of AD and is also one of the most troublesome symptoms in AD 1) 2)
. The discomfort of itching causes anger and irritation in AD patients and in family members. The itching sensation disturbs sleep, work, school and social life in AD patients for a long period of time, and eventually their quality of life (QOL) will be debased. The effective control of itching will contribute to controlling the skin lesions and to improving the patientsʼ QOL. The purpose of our study was to suppress the intolerable itching sensations which are not readily cured.
YKS, a traditional Japanese medicine, has been used as a remedy for neurosis, insomnia, and children with night crying. Since Iwasaki et al.
7)
reported that YKS is effective for treating BPSD in a randomized, observer-blind, controlled trial in 2005, many basic and clinical studies using YKS have been reported. Clinically, it has been reported that YKS ameliorates excitement, anger, and hallucinations in BPSD, and in patients with Alzheimerʼs disease. Treatment of BPSD with YKS has been successful in clinical cases of dementia with Lewy bodies, Parkinsonian dementia and other forms of senile dementia, and also treatments of neuropathic pain, schizophrenia and restless legs syndrome with YKS have been successful 7)-14)
. Basic research has shown that YKS regulates both serotonin signaling and glutamate signaling. Serotonin is made from tryptophan and suppresses the excitement of neuronal cells. Serotonin receptors now number more than 14, one of them being the 5-HT1A receptor. YKS is a partial agonist of the 5-HT1A receptor, and down-regulates the 5-HT2A receptor. Terawaki et al. 37) suggests that YKS ameliorates the development of AD-like skin lesions and scratching behaviors in NC/Nga mice due to a mechanism different from fexofenadine. YKS suppresses the activity of NMDA receptors and enhances the activity of GLT-1 in the skin. We expect that YKS inhibits NMDA receptors and activates GLT-1 by adjusting the extracellular concentration of glutamate in the skin of NC/Nga mice. Further study is necessary to characterize the mechanism(s) of glutamate signaling and the relationship between the itch sensation and glutamate signaling function in the skin of NC/Nga mice. The authors plan to investigate the role of glutamate in the induction of itch sensation in future experiments. This study showed that YKS was effective for treating AD-like skin lesions with NC/Nga mice, and might be a useful therapeutic strategy for AD patients with BPSA under stressful conditions. In addition, we disclosed the glutamate signaling pathway involved in the AD-like skin lesions with NC/Nga mice. Our latest study 38) is the experiments in vitro. In the cultured keratinocytes, the extra-cellular concentrations of glutamate increased as the cell density increased. We observed increased glutamate concentrations in the AD-like lesion of conventional control mice. However, we observed that the glutamate concentrations were decreased in the skin of YKS-treated mice. The glutamate concentration and dermatitis score were correlated. Dermatitis lesions can produce and release excess glutamate. These results suggested that YKS reduced the excessive glutamate production in NC/Nga mice skin. We speculate that this increase originated from an outflow of glutamate from the keratinocytes. We demonstrated that YKS suppresses the activity of NMDAR2D-type receptors in cultured keratinocytes. NMDA receptors reside on keratinocytes and are known to be involved in the process of skin barrier repair .YKS, which is also an NMDA antagonist, might improve skin barrier function.
Conclusion remarks
In conclusion, we suggest that YKS affects both the epidermis and the CNS. YKS might be an alternative or a complementary therapeutic option for the treatment of patients with severe pruritus and dermatitis, such as BPSA. Further more detailed experiments are necessary to clarify the precise functional nature of epidermal glutamate signaling and its medication by YKS.
